We are live on
!
Find out more
SR
Summer Road Portfolio holdings
AUM
$161M
1-Year Est. Return
27.24%
This Fund
S&P 500
This Quarter
Est. Return
-28.05%
1 Year Est. Return
+27.24%
3 Year Est. Return
+129.62%
5 Year Est. Return
-16.44%
10 Year Est. Return
+274.48%
AUM
$24.1M
AUM Growth
-$6.19M
(-20%)
Cap. Flow
+$4.17M
Cap. Flow
% of AUM
17.34%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ocular Therapeutix
OCUL
|
+$4.17M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 62.56% |
| 2 | Consumer Discretionary | 37.44% |
Similar funds
SFCM
LWM
MWM
MCM
BFS
MMCM
MWA
BWM
Summer Road's Q4 2018 Portfolio in Review
As of Q4 2018, Summer Road held 2 positions worth $24.1M, down 20% from $30.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Summer Road deployed $4.17M of net new capital in Q4 2018, adding to 1 existing holding.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, down from 69% a quarter earlier, followed by Consumer Discretionary.
- Summer Road added most to Ocular Therapeutix in Q4 2018, an estimated $4.17M increase.
- Summer Road's ten largest holdings make up 100% of its $24.1M portfolio in Q4 2018.
- Summer Road opened 0 new positions and closed 0 in Q4 2018.
- Summer Road's portfolio value fell 20% quarter-over-quarter to $24.1M.
Based on Summer Road's 13F filing for Q4 2018, filed 14 Feb 2019.